Normi Brück

Rapid and Sustained Remission of Systemic Juvenile Idiopathic Arthritis-Associated Macrophage Activation Syndrome Through Treatment With Anakinra and Corticosteroids

Normi Brück, Meinolf Suttorp, Maria Kabus et al. · JCR Journal of Clinical Rheumatology · 2011 · 142 citations

Life Sciences, Immunology, Pharmacotherapy +15

Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)

Christian M. Hedrich, Normi Brück, B. Fiebig et al. · Rheumatology International · 2011 · 50 citations

Medicine, Clinical Sciences, Pharmacotherapy +5

Interferon signature guiding therapeutic decision making: ruxolitinib as first-line therapy for severe juvenile dermatomyositis?

A. Heinen, Anja Schnabel, Normi Brück et al. · Lara D. Veeken · 2020 · 23 citations

Medicine, Dermatology, Immunology +14

“Mutation negative” familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies

Christian M. Hedrich, Normi Brück, Diana Paul et al. · Rheumatology International · 2011 · 18 citations

Life Sciences, Genetics, Pediatrics +11

Good response to IL‐1β blockade by anakinra in a 23‐year‐old CINCA/NOMID patient without mutations in the<i>CIAS1</i>gene. Cytokine profiles and functional studies

Christian M. Hedrich, B. Fiebig, S. Sallmann et al. · Scandinavian Journal of Rheumatology · 2008 · 17 citations

Life Sciences, Dermatology, Immunology +16